GGHC
AXNX

Gilder Gagnon Howe & Co’s Axonics, Inc. Common Stock AXNX Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-19,256
Closed -$1.05M – 342
2023
Q1 		$1.05M Buy
+19,256
New +$1.12M 0.02% 197

Other funds holding AXNX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Gilder Gagnon Howe & Co's AXNX Position: Q2 2023 in Review

Gilder Gagnon Howe & Co sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2023, closing a stake of 19,256 shares — an estimated $1.05M sold.

Gilder Gagnon Howe & Co first reported a position in AXNX in Q1 2023 and held it in 1 quarter. The position peaked at $1.05M in Q1 2023. 235 funds tracked by Wall St. Rank hold AXNX as of Q2 2023.

  • Gilder Gagnon Howe & Co reported no remaining Axonics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 19,256 Axonics, Inc. Common Stock shares in Q2 2023, an estimated $1.05M.
  • Gilder Gagnon Howe & Co first reported a position in Axonics, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Gilder Gagnon Howe & Co's Axonics, Inc. Common Stock position peaked at $1.05M in Q1 2023.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2023.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2023, filed 14 Aug 2023.